Journal Home
Search for

Articles in Press

Return to articles in press list

Early phase insulin secretion is increased in subjects with normal fasting glucose and metabolic syndrome: a premature feature of beta-cell dysfunction

L. Spadaro, C. Alagona, F. Palermo, S. Piro, S. Calanna, G. Parrinello, F. PurrelloCorresponding Author Informationemail address, A.M. Rabuazzo

Received 4 March 2009; received in revised form 29 July 2009; accepted 7 September 2009. published online 22 January 2010.
Corrected Proof

Abstract 

Background and Aims

Metabolic syndrome (MS) has been mainly related to insulin resistance, but the role of changes in insulin secretion has not been thoroughly investigated.

Methods and Results

Using an oral glucose tolerance test (OGTT) we studied beta-cell function and insulin sensitivity in subjects with normal fasting glucose with and without MS, and their relationship to fatty liver which was evaluated by abdominal-ultrasonography. In MS early phase insulin secretion, as measured by insulinogenic index (IG30), was increased (p<0.05) independently from insulin sensitivity. Furthermore IG30 was progressively higher as the number of factors needed for the diagnosis of MS increased (p<0.01). Insulin and C-peptide AUC were also increased (p<0.01 and p<0.05, respectively) but, in contrast to IG30, these differences disappeared when ISI was used as a covariate. After OGTT, 51% of the subjects with MS had altered post-load glucose tolerance compared to 24.9% without MS (p<0.01). In both groups, the altered glucose tolerance was associated with a similar IG30 reduction. In normo-tolerant subjects with MS the IG30 was higher (+54.1%, p<0.01), and this elevation occurred irrespective of ISI; however, the beta-cell compensatory capacity for insulin resistance (disposition index) was impaired (p<0.001). Fatty liver was more frequent (p<0.001) and more severe (p<0.01) in MS, and it was significantly related to total AUC-insulin (p<0.001), independently from ISI.

Conclusion

These findings indicate that the prevalence of altered tolerance is more frequent in subjects with normal fasting glucose and MS. The hyperinsulinemia might not only be an adaptive response to insulin resistance, but a primary defect of beta-cell function contributing to glucose intolerance.

Dept. di Medicina Interna e Medicina Specialistica, Università degli Studi di Catania, Ospedale Garibaldi, Italy

Corresponding Author InformationCorrespondence author. Clinica di Medicina Interna, Ospedale Garibaldi “Nesima”, Via Palermo, 636, 95122 Catania, Italy. Tel.: +39 0957598401; fax: +39 0957598421.

PII: S0939-4753(09)00216-6

doi:10.1016/j.numecd.2009.09.003